Dexmedetomidine
Dexmedetomidine is a selective alpha-2 adrenergic receptor agonist used for sedation in intensive care units and during certain surgical or diagnostic procedures. It works by reducing sympathetic nervous system activity, producing sedative and anxiolytic effects while generally causing less respiratory depression than many other sedatives. Dexmedetomidine is typically administered by intravenous infusion under continuous clinical monitoring. Depending on the approved formulation and local guidelines, it may be used for sedation of mechanically ventilated adults or patients undergoing procedures. Common adverse effects include low blood pressure, slow heart rate, and dry mouth. Because it can cause significant cardiovascular effects, administration requires trained healthcare professionals and monitoring of heart rate, blood pressure, and oxygenation.
Dexmedetomidine was historically used as a respiratory medicine for the symptomatic management of certain respiratory conditions. Its former uses included:
is okay
The import of medicines into India is regulated by the Central Drugs Standard Control Organisation (CDSCO) under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The regulatory requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished formulation, or an unapproved medicine intended for an individual patient's treatment.
Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Dexmedetomidine, subject to confirmation of its current regulatory status and eligibility for import into India.
The export of Dexmedetomidine from India is subject to applicable requirements under the Drugs and Cosmetics Act, 1940, the Drugs and Cosmetics Rules, 1945, and relevant export, customs, and destination-country regulations. Documentation requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished pharmaceutical formulation, or a medicine intended for a specific market. Export eligibility and destination-country requirements must be verified before shipment.
Primeera Healthcare Private Limited can provide pharmaceutical export documentation assistance, regulatory coordination, and shipping support for Dexmedetomidine, subject to confirmation of its export eligibility under applicable Indian regulations and the import requirements of the destination country.
If you have any questions or need any help, contact our Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
All Trademarks and Brands that appear on the website belong to their respective owners. Primeera Healthcare does not lay any claim on them; we only provide information.
